Needham v. White Laboratories Inc‪.‬

In 1946 the Food and Drug Administration ("FDA") authorized defendant-appellant White Laboratories, Inc. ("White"), to market dienestrol, a synthetic estrogen, for the treatment of menopausal symptoms and suppression of lactation. In 1950 the FDA authorized White to market dienestrol for treatment of threatened and habitual miscarriages.